PADDING
UNK
,
drug1
drug2
drug3
drug0
the
)
(
and
of
in
.
with
0
to
rs0
-
a
patients
:
0.0
/
that
*
for
polymorphisms
by
gene
on
we
were
or
is
as
=
was
not
are
%
p
cyp0a0
cells
induced
response
study
be
treatment
;
an
cancer
associated
cyp0c0
but
levels
polymorphism
this
between
results
association
genes
allele
clinical
from
treated
expression
genotype
cell
effects
significant
receptor
may
who
risk
cbz
at
>
mutations
mutation
inhibitor
abcb0
effect
these
after
c
egfr
combination
therapy
human
has
which
compared
than
survival
increased
sensitivity
our
significantly
reduced
have
mutant
no
protein
found
chemotherapy
did
genetic
subjects
showed
higher
toxicity
[
conclusion
factor
.0
lower
-0
including
based
resistance
when
mice
p0
vegfr0
metabolism
]
nasal
kinase
0:0
activity
<
+
well
growth
alleles
l
lung
tumor
warfarin
controls
also
conclusions
function
among
tnf
overall
other
single
population
background
cxcl0
''
dose
reduction
dependent
vivo
advanced
phase
wild-type
cftr
one
trial
studies
chinese
variability
assessed
administration
alcohol
plus
group
promoter
whether
epidermal
progression-free
present
had
increase
0.0-0
n
methods
influence
using
decreased
breast
used
vkorc0
chronic
concentrations
those
snps
nsclc
efficacy
decrease
detected
carriers
potential
hla-b
homozygous
role
nucleotide
drugs
suggest
been
pilot
t
met
cadrs
genotyped
doses
first-line
objective
tumors
both
plasma
hla-a
during
genotypes
only
more
their
predictor
syndrome
epithelial
0/0
transporter
status
her0
tolerant
thus
high
improved
pfs
model
mtx
suggesting
tacrolimus
show
such
key
restored
common
related
age
nine
whereas
kras
inhibitors
aim
ratio
however
its
either
affect
renal
can
b
while
it
lines
il0
dependence
serum
snp
vegf-a
recist
pdgfr-a
surviva
all
major
carrying
tyrosine
two
receiving
ligand
+0.0
analyzed
ii
exon
gsto0
pik0ca
greater
require
s
ephx0
odds
sunitinib
abundance
correlating
sputum
involving
transcripts
brushing
following
mdr0
functional
comt
inhibition
pharmacokinetics
demonstrate
variants
g
hepatitis
egcg
daily
blood
i
oral
apoptosis
tnf-alpha
positive
recipients
sweat
necrosis
could
women
f0del
metastatic
findings
c-x-c
chemokine
differences
becn0
motif
cf
type
'
resistant
some
activation
although
cancers
ten
colorectal
changes
analysis
c0t
early
lansoprazole
line
transplant
evaluate
chloride
within
sjs
exposure
first
against
respectively
investigated
relation
individual
level
factors
sustained
implying
through
maintenance
clearance
cysteamine
ratios
influenced
patient
data
sqstm0
glutathione
involved
confidence
interval
hepatic
braf
populations
coronary
cyp0d0
dehydrogenase
examined
four
drug
combined
cases
0g
ribavirin
irinotecan
might
examine
angiotensin
previous
test
risperidone
responses
healthy
r
ace
muscle
known
whose
paclitaxel
virological
female
strongly
associations
specificity
acid
schizophrenia
melanoma
h
studied
methotrexate
assess
cocaine
support
mrna
development
vntr
vs.
presence
better
six
abcc0
variant
's
liver
review
predictive
single-nucleotide
tkis
hypersensitivity
serotonin
induction
lsz
0-fu
interindividual
different
mthfr
variation
evidence
cyp0f0
purpose
tyms
use
and/or
agonist
impact
crizotinib
negative
arg
relapse
0a
toxic
rate
gstp0
each
slc0a0
correlation
demonstrated
a0n
into
enzyme
investigate
cytochrome
sensitive
gstm0
adverse
indicate
where
previously
invasive
measured
chc
platinum
hla
models
rise
expressed
outcomes
reductase
ci
baseline
several
-0.0
multiple
years
substitution
ethanol
modifying
0-fluorouracil
gstt0
overuse
sorafenib
val0met
ppi
rr
exposed
result
stage
aa
percutaneous
mean
normal
rat
interaction
apply
cc
gsta0
tnbc
transferase
losartan
important
necrolysis
tpmt
receptors
hbv
contribute
harbored
increases
rh
regression
body
pathway
hsp0
affecting
deletion
target
performed
vitro
direct
predict
acute
erlotinib
c-raf
headache
non-small
contrast
missense
moh
codons
expressing
mutated
due
basis
gst
without
formation
e
death
showing
slco0b0
occur
bladder
gefitinib
frequently
frequency
control
experimental
intervention
treatments
estradiol
antigen
tamoxifen
inhibiting
total
difference
find
observed
included
maculopapular
hss
exanthema
moreover
mpe
virus
a/g
depression
ifn-alpha
concentration
haplotype
synthase
enhanced
predictors
reported
stevens-johnson
agents
0-htt
effective
mg
point
testing
similar
cetuximab
metabolites
inosine
alone
dna
antibody
directed
--
comparison
hla-c
elevated
ras
failed
heroin
occurrence
sk-ov-0
signaling
system
activated
overexpressing
benefit
inducing
nicotine
mma
determine
groups
cisplatin
enhances
lipoprotein
male
c-0
pharmacokinetic
established
insertion/deletion
wfs0
0-0
mouse
proc
ggcx
0-httlpr
clopidogrel
genotyping
therapeutic
recently
rates
shown
achieve
pz
g.-0g
favorable
drd0
p.i0l
p.r0c
mainly
isolates
analyze
targeting
any
aims
similarly
a0c
0-mercaptopurine
rfc0
unassigned
trastuzumab
prevalence
caused
auc
dat
bcl-0
mediated
specific
disorder
accumulation
amplification
pharmacogenetic
metabolic
homologous
before
il-0
value
skin
inhibits
cda
insulin
aspirin
affinity
p.glu0lys
nucleoside
carcinoma
improvement
skipping
conferring
do
apoe
l0r
same
0-aag
suggested
cyp0
leukemia
affected
dpyd
under
tested
channel
new
delayed
mdri
thrombosis
detoxification
tissue-binding
preventing
novel
hematopoietic
m0t
pci
i/d
0-fold
recent
afatinib
cholesterol
thiopurine
codeine
driven
area
regulated
depletion
oncogenic
co-mutation
0c
number
possible
prognostic
brain
t0c
encoding
multidrug
less
interferon
disease
individuals
together
low
native
ins/del
ve
considered
nicotinic
distribution
carboplatin
estrogen
ugt0a0
induce
ovarian
addiction
neurons
regimen
statistically
tki
proteins
epirubicin
activities
markedly
disorders
regardless
tt
affects
design
upfront
help
should
lipase
hfe
cohort
nrf0
outcome
potent
infection
tnfalpha
events
medication
program
subunit
clinically
nuclear
il0b
dopamine
include
concentration-time
triglyceride
would
simple
na
treat
activating
leads
selective
bprs
twenty-four
current
correction
snpspd
required
symptomatic
elevation
there
strong
chi0
angiotensinogen
restenosis
delivered
dma
mcl
understanding
single-agent
further
controversial
converting
androgen
still
at0r
tki-na
germline
susceptibility
agt
designed
smoke
jak0
potently
size
s-methyltransferase
us
received
lpr
peginterferon
region
nucleus
gastric
crc
0-mg
developed
ability
vemurafenib
case
borderline
glucose
down-regulation
taking
personality
marked
excellent
possibly
identified
japanese
contributes
antagonist
steps
antiapoptotic
thymidylate
later
fact
injury
interferes
analyses
accordingly
median
mek0/0
carry
recombination
c.
his0arg
arrest
requirements
characteristics
reduces
microg
pharmacogenetics
b-raf
intraperitoneal
interactions
twice
confer
weight
a0
prior
i.e.
percentiles
g/a
induces
0th-0th
mitochondrial
acutely
kappa
pharmacodynamic
0-oh
delta
day
additional
mu
basal
deoxycytidine
relationship
tam
history
mdr-0
m0v
manner
opioid
randomized
appears
binding
v0e
hiv-0
vegf
authors
variations
standard
clear
transfer
pathways
cellular
adjusted
implication
confirmed
pyrophosphatase
pd-0
stages
triphosphate
relevant
lapatinib
metabolizers
probably
a0/a0
days
proliferation
fat
dehydroepiandrosterone
idarubicin
fludarabine
prima-0
cddp
haloperidol
regulatory
preclinical
quinapril
a-0g
inhibited
non-r/r
biomarkers
controlled
transaminase
taqia
alt
harboring
camp
anti-hbe
positivity
r/r
condition
features
pharmacological
renin-angiotensin
neu
taqib
alfa
inducible
alanine
deficiency
hypothesis
targeted
ugt0a
udp-glucoronosyltransferase
thereby
endothelial
atherosclerosis
0fu
cys
enhance
adenocarcinomas
drug-resistance
arsenic
reverse
g0
obtained
glutamate
men
acquired
chemotherapeutic
cr
according
cyp0b0
provides
improve
considering
enhancement
expressers
simultaneously
elucidate
cyclin
tablets
caucasian
discuss
attributed
generated
indicating
alk
highest
in-depth
fentanyl
pth
transient
strain
essential
adult
particular
phosphorylation
tki-resistant
co-trimoxazole
e-0
maoa
excretion
profile
months
0-htr0a
l0m
ercc0
v0i
values
dose/week
gemcitabine
antiretroviral
elimination
ar
lead
seen
stress
vdr
helicase
iii
primary
foci
linear
disposition
creb
having
poorer
cbz-epoxide
kidney
celecoxib
screened
approved
lesions
sample
persistent
report
htert
symptoms
inhibit
efavirenz
severe
0-month
responded
apparently
release
iron
hypothesized
prevented
promoted
refractory
appear
screening
rt
er
azd0
rechallenge
open-label
regulation
safety
dyes
possibility
rejection
responsible
testosterone
smoking
general
0,0
brca0
member
because
selection
subgroups
m0
minor
yet
oxidase
hepatocellular
transcription
contributed
excitingly
rb0
animal
ad
abacavir
inter-individual
pretreatment
doxorubicin
methylenetetrahydrofolate
depressive
continued
hlsz
predispose
dabrafenib
self-administration
nelfinavir
z
sulphone
mechanism
consistent
0b
cautiously
da
gene-environment
remained
worldwide
vhl
lszs
indicative
shorter
contributing
kinases
predicts
mitomycin
oxaliplatin
limited
published
hydroxy
ct
much
enzymes
molecular
undergoing
equilibrative
alterations
indinavir
tapering
dck
high-density
time
schizophreniform
e.g.
ribonucleotide
nrtis
episode
autocrine/paracrine
q0m
murine
multivariate
performance
phosphoribosyltransferase
interventions
angiogenesis
rrm0
acetylcholine
hent0
selected
tumour
differentiation
transcriptional
activates
cigarette
yeast
apoc0
properties
epoxide
vascular
especially
cardiac
apoa0
hence
acetyltransferase
recruitment
ng
regulate
overview
bmd
npy
src
il-0alpha
transcriptase
predominantly
governed
asn
bioactivated
asp
mcp-0
apoe0
girk0
via
taqi
cetp
glucokinase
modulates
give
three
organic
anthracycline
knockout
monoclonal
imatinib
bcl-x
critical
carrier
mcj
hypoxanthine
radicicol
0-allylamino-demethoxygeldanamycin
ser0ser
anti-
demonstrates
humanized
taxol
block
late-stage
pregnancy
regulates
antidepressant
s-transferase
phenotype
nor
risks
i/ii
esrd
hla-g
targets
car
nsc
cytosolic
0-0-fold
dsb
f0
icl-induced
deaminase
frequencies
useful
aldh0
yield
aldehyde
chrna0
0.0-fold
density
fall
colonic
detect
cardiovascular
codon0
about
modulator
recurrence
furthermore
revealed
estimated
extracellular
applied
adjustment
markers
secretion
rad0
evaluated
ho-0
indian
defects
abolishes
drinking
sd
checkpoint
irreversible
another
conditional
fa-d0
invasion
wrn
cdx0
statins
volunteers
adrenergic
determining
behavioral
pancreatic
corresponding
nmda
sert
oxide
promising
intestinal
tissue
cq
pcorr
loss
greatly
hemoglobin
ret-ptc-0
hr
many
presented
bez0
western
nitric
towards
involvement
unresectable
provided
ssri
follow-up
postmenopausal
percentage
urine
profiles
c-fos
impaired
express
followed
correlate
dosing
cyclophosphamide
cyp0e0
vs
modulate
dose-adjusted
y
peptide
surface
oncogene
korean
preoperative
second
adults
d0
ethnicity
pathway-related
derive
dgf
uptake
docetaxel
diplotypes
cat
methamphetamine
sulphation
pact
hydrolysis
absorption
tea
enos
nf-kappab
glycine
uncertainty
conjugation
morphine
pd
glucuronidation
agent
vaccine
active
etoposide
capecitabine
c0
marker
val
magnetic
y0
atp-binding
vasospasm
individually
ala
neuronal
genome-based
interactive
isoform
fraction
withdrawal
covariates
superior
tca-b
isoforms
techniques
heart
regressions
produced
multicentre
resonance
them
converging
hypertension
likely
hk0
cassette
abnormal
tulip
overexpression
cytidine
mbp
subfamily
tnf-b
blocking
mercury
solvents
gendep
aggressive
long-term
most
beta
part
anticancer
heterozygotes
multicenter
sequencing
alelle
dapt
norepinephrine
addicted
fumigatus
ry0-0
erk0/0
singapore
revolutionized
placebo
n/s
determinants
haplotypes
reporter
shows
determined
la/g
african
constitutive
chance
schizoaffective
abca0
reuptake
repression
episodes
abated
non-synonymous
constructed
prevention
since
0d0
dutch
duodenal
inventory
hsp0beta
immunogenicity
beck
recall
inventory-ii
france
log-transformed
subclone
systematic
monophosphate
beta-fibrinogen
weight-adjusted
pressure
twenty-seven
mimicking
svr
enterocyte
embryonic
0-year-old
subscale
ku0-0
c/d
merieux
situations
exhibited
encoded
kg
defined
skov-0
antiproliferative
0-o
hypotheses
non-expressers
mitotic
xanthine
lyon
cmi
institut
irradiated
ret
ectopic
egfp
tranferases
stem
smaller
engineered
lethally
self-reported
pre-selected
enantiomer
multitest
identifying
diet
achn
enrolment
mozambique
promotes
hsp0alpha
regions
inorganic
specifically
alter
progression
reliable
cox-0
independent
summary
emphasizing
hscrp
pew
nephrogenous
0-week
adipose
reabsorption
driver
white
mlkl
relative
rip0
lack
intact
highly
d-aspartate
n-methyl
instrument
nat0
slow
mg/kg/day
albumin
eralpha
fibroblasts
curves
0d
dimethylarsinic
extensive
european
monomethylarsonous
versus
correlated
ll
characterized
diol
tobacco
containing
immunohistochemistry
translate
locally
low-dose
vitamin
mesylate
prognosis
large
acetaminophen
co-administered
asthma
arry-0
intrinsic
selumetinib
improves
concomitant
evaluation
nnk
utility
so
psa
inositol
nav0
ventricular
c0y
mammary
non-small-cell
terms
d
oxidative
calcium
adh0b
preference
mutation-positive
viral
neoadjuvant
polymerase
ser0gly
abuse
bortezomib
prospectively
pattern
reaction
urinary
htr0a
meta-analysis
escitalopram
membrane
adrb0
diagnosis
alcoholism
channels
behavior
stent
agonists
hcv
dynamics
weeks
ts
itpa
grade
xeroderma
anti-angiogenesis
potency
inhalation
fibrosis
circulating
opposing
tnf-a
curve
plasmatic
molecules
phenotypes
ifn-gamma
bevacizumab
measures
immune
venous
skeletal
desensitization
pigmentosum
antioxidative
classes
dosage
endogenous
therapies
therefore
childhood
cycling
cation
oct0
per
genetically
c-kit
lncap
injection
diabetic
cyp0a
htr0b
playing
isoniazid
replaced
b0-receptor
sexual
ccl0
failure
anthropometrics
inh
pooled
rationale
particularly
deoxythymidine
azido-0
suppressed
adh0
scnn0a
enhancers
gender-matched
acetylation
sulfate
androstenedione
kuwaiti
interference
ces0
spliced
humans
synthetic
b0
degree
ethinyl
change
nortriptyline
atm
adenosine
psychotic
synonymous
muraglitazar
tumours
0-ht0ab
ip
converts
weak
oprk0
fda-approved
c-jun
importantly
tricyclic
plays
harbouring
already
nsclcs
intensity
hanover
omega0
adding
lymphoma
gg
attenuate
nj
novartis
pharmaceuticals
malignant
anxiety
located
antialcoholism
malignancies
ssris
resistance-associated
her-0
doublet
solid
epigallocatechin
ester
ht
jo0
pc0
glioma
hepatocyte
temperature
hyperabsorption
avt
free
se
c-abl
suppressing
spontaneous
tcpobop
phosphorylated
g0n
production
egc
c0tpolymorphism
disulfiram
hla-g0
pdgf-r
gh
fatalities
finding
h/ml/mg
ng/ml/mg
types
limits
relationships
dsf
stromelysin-0
epigallocatechin-0-gallate
alpha0
cholesteryl
two-fold
0-ht
cu
ankk0
up-regulating
a-0c
aimed
barely
sjw
maternal
alpha0beta0
chronopharmacokinetics
work
once
poor
genomic
five
hb
centrally
hoxb0
cck
ad0
chain
piece
play
likelihood
atypical
non
younger
lamivudine
gastroesophageal
intensive
engraftment
azathioprine
xenograft
myocardial
entire
cbz-diol
describe
encodes
ems
dystonia
disrupted
given
substrates
craving
granted
respect
synthesis
transfected
approval
specification
hepatotoxicity
pre-treatment
blot
multilineage
dth
siha
reinstating
trag-0
immunocompromised
v0k
saos-0
usual
protocols
az
impressive
deferoxamine
striatum
occasional
assay
intrathecal
subacute
postoperative
fusion
mesoderm
progenitor
intracerebroventricular
competence
antigens
larger
ser0
hypoxia
threshold
a.
explored
older
accumbens
entities
suggests
myeloid
loading
adv
leukaemia
limit
accounted
radiosensitization
lowest
matrix
hazard
commenced
oscc
consecutively
interferon-free
ng.h
well-tolerated
glycogen
adjuvant
end
very
a0g
analogs
seems
characteristic
meh
ile
stomach
worse
dominant
oh
cultures
approach
ml/mg/kg
currently
phosphate
chc-i
feature
pms
infusion
logistic
sensitization
action
posaconazole
icotinib
respond
salbutamol
diminished
stimulated
m
indicated
wt
up-regulated
prasugrel
hypermethylation
sult0a0
endocrine
focused
objectives
infected
identical
abnormalities
cd0
management
extent
seem
partial
availability
pain
setting
subset
decreases
damage
thai
mek
high-risk
supplement
introduced
poor-risk
mutants
identify
oprm0
tenofovir
transplantation
ipass
favored
mds
valspodar
intravenous
psc
suppressive
addition
slight
gene-0
separate
upstream
protective
aml
hormone
immediately
ibruitinib
aromatase
p-fluorofentanyl
trials
xiap
tag
mutagenicity
mabs
fluorescent
myocyte
b-catenin
n-cadherin
widely
metabolizing
situ
additive
gck
child
trait
estrone
metabolically
cd
distinguished
lenalidamide
currents
cerebral
cyclosporine
paper
tk
vimentin
btk
gckr
homocysteine
hamsters
e-cadherin
p-fluoro
biochemical
hybridization
fish
fluorofentanyl
index
mineral
biotherapy
streptozotocin
emtricitabine
arrays
s0
reward
newborn
ihc
e0
bruton
paroxetine
bone
mixed
treatment-naive
series
nfkb
fracture
deletions
post-transplantation
sirt0
p0l
pdyn
retrospective
randomised
minimal
loss-of-function
nevirapine
out
nvalt
place
application
excluding
single-stage
influences
single-arm
tac-qd
irene
re-challenge
pulmonologists
iressa
stratified
basal-like
hemodialysis
leading
generally
0hbe0o
dimethoxyquinazoline
displays
ps
pertinence
despite
hsc-0
remarkable
npy0r
syndromes
correlations
asian
african-specific
stroke
lithium
analogues
0-ohdg
whi-p0
kainic
bax
cell-specific
janex-0
example
intronic
tymp
0-0-0
infarction
translocations
cigarettes
gilotrif
beta-hydroxylase
over
r0
fourteen
vi
ranging
,0
near
triple-negative
bulk
ces
foki
antagonism
consumed
nvp
asn0ser
non-selective
information
analog
year
polyps
month
participates
nominally
hydroxyphenyl
discussed
pr
consumers
lymphovascular
requiring
n-methyl-d-aspartate
males
allografts
complex
erbb-0
fos
psychosis
ne
cooperative
post
amino-0
sessions
copper
mdma
cas
pkai
consequences
acs
smokers
alteration
dbh
caffeine
tetracycline
asked
focus
islet
thienopyridines
pleomorphism
polyphenols
mechanisms
investigation
documented
reactions
postoperatively
laboratory
auy0
nonsmall
interacts
immunomodulation
fewer
ldl
aberrant
illustrate
core
genetics
monotherapy
coadministered
inductive
evodiamine
metabolites-had
mncl
strains
osmotic
develop
platelets
utr
pstat0
negatively
expansion
mcrc
linkage
antisense
chu0
experiments
flashes
0-all
nac
taxane
dyskinesia
testis
stasis
disequilibrium
ifn-a
absolute
selectively
homeostasis
pi
overcoming
traits
incentive
protocol
bss
hot
und
fell
altered
p0ink0a
hcc-0
gsts
msns
interestingly
hippel-lindau
a-0
reliably
shell
thr0arg
transiently
hemachromatosis
ls
indices
follicles
pegylated
subgroup
antiestrogenic
mt
nqo0
bath
turkish
systematically
protected
toward
von
kinetics
rapid
investigating
consisting
comparisons
post-pci
indicates
radiation
bile
consolidation
within-gene
cohorts
surprising
transforming
apomorphine
autochthonous
repeated
hydroxylase-immunoreactive
distributed
minutes
abcg0
phenotypic
predisposition
talinolol
geographic
signature
height
discovered
0-mthf
enrollment
supported
seeking
apc
s0c
medial
bleeding
networks
commissural
score
chs0
idh0
oxygenation
fkbp0
abusers
profiled
bali
adenocarcinoma
metastases
hiv
apart
tlr0
incidence
precipitated
period
ros0
sirna
cholinesterase
lymphoblastic
dysregulation
combining
chf0
starting
supports
areas
attributable
benefiting
regresses
confocal
parameters
pronounced
microscopy
downstream
profound
cll
sulfide
0alpha,0-dihydroxyvitamin
cn-aml
diabetes
0q
removal
throughout
ipa
phenotypically
0-ht0
therapy-pretreated
grin0a
fas
nts
candidate
interleukin
subnuclei
os
delays
cance
inferred
?
substrate
extrusion
toxin
myelodysplastic
explore
cfos
triggered
mate0
mutation-negative
mg/kg
suppressor
demonstrating
cudc-0
arg0trp
bcl0l0
aerd
rbv
heterozygous
mek0
i0c
ugt0b0
protects
neither
additionally
survivin
pd0
rare
fmo0
hrqol
able
conversion
symptom
u0
endpoints
crohn
pmol/min/mg
americans
needed
synergism
nigrostriatal
resulted
genetic-potentiated
piperazine
temsirolimus
m-chlorophenyl
rdea0
thyroid
does
contributions
0a0
lowering
final
molecule
dose-dependent
h/ml
eml0
double
secondary
non-drug
prostate
escalating
even
myoclonus
discussion
lam
subsequent
bsc
translocation
injections
modulation
derived
network
infinity
makes
caspase-0
bdnf
t0a
endometrial
led
signal-regulated
adenoma
signs
mellitus
decline
anaplastic
c/t
schizophrenic
skm0
phosphatase
butanone
suspected
ttx
polyphosphate-0-phosphatase
cytarabine
p-glycoprotein
methylnitrosamino
mono
ippase
max
substituting
beas-0b
sarcoma
blockage
homologue
tetrodotoxin
retrospectively
luminal
japan
reversible
rsgfp
heat
pharmacodynamics
gsk-0
nitrosamine
sinthase
fluorouracil
cyclooxygenase
cyclophosphamid
leucine
experimentation
correlates
transport
juglone
impase
0-pyridyl
provide
s-0
catecholamine
orally
patterns
trametinib
appropriate
v-raf
airway
melanomas
lipid
until
adolescent
arg0gly
mediate
compounds
carried
0t
mimicked
recurrences
htpr
actively
functionally
xpa
mglur
maf
galr0
untreated
pxr
conjugated
haplotypic
panss
argues
prescription
crt
enterocytes
fmr0
done
wall
regard
bm
cycles
haplotype-dependent
telaprevir
physiological
self-infusion
how
hepatocytes
clearly
constructs
occurring
platelet
then
intriguingly
sulfotransferase
scale
structure
comprising
galanin
fr-pqbi0
adh
slightly
abortion
pegifn
opiate
inferior
comprehensive
xpd
terminal
pegylated-interferon
structurally
experiment
monkeys
ikappabalpha
reinstatement
anastrozole
newly
degrades
determination
susceptible
dorsalraphe
post-transplant
m-cpp
concurrent
blockade
subjective
tolerance
apnoea
distinguish
makers
presumably
0h
profoundly
topography
partner
seizures
purine
innately
young
personalized
elevates
alkylating
regulators
mu-opioid
high-activity
triallelic
outpatient
mmp-0
intestine
ddp
fetuin-a
pathological
unconjugated
subtypes
etiology
s-warfarin
suppression
equivalent
transports
dextromethorphan
suxamethonium
naturally
myelogenous
discrete
keratinocyte
r0s
antiplatelet
diverse
families
copy
hemizygous
truncated
instead
animals
pct
rhesus
0-oh-tam
x
apai
differ
terminally
adenomas
myelosuppression
computer-assisted
definitive
shortened
putative
unilateral
preferred
content
dd
understand
cues
mmc
homozygosity
sensitizes
hypersensitive
histone
heavy
chronically
speculated
min
fertility
comparative
stable
antitumor
relevance
carvedilol
histological
retinoic
all-trans
striatal
down-regulates
amp
age-adjusted
consequence
predicted
paraventricular
ro0
sm0
alosetron
contains
ch0
gaba
late-onset
kb
runx0
lineage
remaining
influencing
0-benzyl-0-hydroxy-0
adjacent
adolescents
dhpg
folic
virtually
experiences
mph
vulnerability
proteasome
forkhead-associated
hla-dr
coenzyme
0-methoxyethoxy
event-free
hel
concentration/weight-adjusted
direction
co-administration
mtor
trough
ogg0
causing
signal
monocytes
cl0
unfavorable
0met
alcoholics
ltd
social
offset
nutlin-0
routine
ctx
arg0cys
approximately
presents
h0
p0waf0
elucidation
immediate
extends
immunoreactive
biopsy
ss
cooperates
central
blocks
gabab
downregulation
foundation
polymorphic
chd0
maximum
distant
endemic
protect
discontinuation
v0
g0/m
abrogators
warrants
reverses
moderated
dichotomized
mediator
periods
mll
modifications
ac0
hla-dq
disappearance
t0m
azole
r0c
staining
suicide
tolerable
nongenotoxic
olaparib
adenine
option
littermates
gabra0
replicated
alpha-hydroxymetoprolol
glucocorticoid
fbat
monitored
ring
solution
relapse-free
statin
ftnd
dramatically
relatively
equally
helped
0v0
canine
cell-based
0-aza-0
define
cis-platinum
high-dose
mostly
tapbp
finger
haplotype-specific
csa
am0
taq0a
osteosarcoma
tegaserod
naa
rabeprazole
knock-down
domain-like
blotting
k0
dramatic
pravastatin
synergistically
accompanied
finnish
rats
hydroxylase
small
inherited
reflect
methimazole
instability
valuable
sulindac
hypothyroid
treating
factor-alpha
are-mediated
aflatoxin
mg/day
non-carriers
taiwanese
apap
phe
challenge
third
amifostine
psychological
deficiencies
remodeling
0c0
regarding
discovery
vinorelbine
elk0
neuropathic
chromatin
isogenic
t/a
undertreated
systolic
methylation
well-being
primarily
scores
ethnic
nonresponders
mor
safe
microsatellite
pretreated
delay
decrement
none
leucocyte
substance
hh
ept
transcript
presentation
reduce
mechanistic
perk0/0
itself
circumvention
augmented
antioxidant
reinvestigated
allopurinol
focusing
supplementation
being
drinkers
noncarriers
tp0
family
k-ras
rgs0
f0l
learning
memory
domain
tandem
trend
identification
whole
coding
reactivated
mao-a
transformed
c-met
p0y0
research
portion
nad
carbamazepine
digoxin
snri
antidepressants
taxanes
tca
mmol/l
axial
here
spatial
domain-containing
amazonian
naloxone
workers
longer
protruded
analgesic
kirsten
peg-interferon
pdd
microsomal
emid0
hyperacetylation
amino-acid
importance
tm0
folate
responds
gonadotropin
facilitated
desensitizes
order
isg
introduction
brazilian
defining
international
y0l
nmr
infertility
v0f
herceptin
pak0
xenobiotics
0tc
ivf
abo
mn
hydroxylation
low-density
-.0
substitutions
four-drug
eukaryotic
prostaglandins
consumption
descent
solute
miapaca0
crystallography
steroid
predilection
alcoholic
iui
emilin/multimerin
onset
dysferlin
arm
exacerbated
water
inhaled
0-hydroxy-tamoxifen
rt-pcr
subepithelial
dhfr
specificities
pfmdr0
normalized
cutaneous
taxotere
brca-0
units
cpg
swelling
users
virologic
hyperthermia
comparable
alpha
transformation
ykt0
hormonal
jun
mm0
cct0
morphological
stenting
0,0-methylene-tetrahydrofolate
evolution
genotypic
australasian
beta0
confirmation
stat
itf0
second-line
cross-resistance
du-0
0beta-estradiol
underlying
nonischemic
left
muscarinic
amphetamine
crf
activator
shop
restricted
mothers
proliferator-activated
egyptian
duplication
high-level
k0/a0
peak
enrolled
c0-like
rectal
bcrp
cilengitide
cardiomyopathy
akt
sirolimus
embryo
triiodothyronine
peripherally
ciclosporin
ppara
b-adrenergic
signalling
gaa
cyclosporin
n0d
g.
raf
bioavailable
ile0val
msi
predicting
immunity
ivs0
cyp
amiodarone
field
c-erbb-0
fgl0
segmental
gababr0
analogous
cho
existence
effluxed
cb0-r
niemann-pick
mgp
equal
performing
beta-d-glucuronide
saururus
principal
inr
infants
0gln0thr0
nphs0
bcss
namely
jtc0
d0-like
quaternary
delta-aminolevulinic
chinensis
gly0gln0thr0
gst-0
met0ile
overcomes
dat0
hematologic
pmh
optimized
c0g
npc0l0
prevailing
pcr
mitogen
french
are0
dogma
pompe
h-ras
cimp-positive
li
tsg
mglu0
aspergillus
available
estrone-0-sulfate
behaviors
inrs
c-sweat
enters
great
conventional
_
-0,0
haplodeficient
fluoropyrimidine
micromol/l
conclude
multi-drug
peroxisome
internal
access
gamma-carboxyglutamic
green
gingival
his
laboratories
holds
transglutaminase
sod-0
ablation
focal
recognized
problematic
translated
glomerulosclerosis
cocktail
systemic
practice
pk
poisoned
poisoning
generalize
k
n-oleoylethanolamine
oea
fexofenadine
titers
ivs0-0a
random-effects
acting
dehydratase
overload
p0r
dihydroxyphenylglycine
progestin
methylene
0insa
usefulness
booster
ezetimibe
now
lineages
thyroxine
corr
examining
chfr
clotrimazole
guarantee
alad
+0
terbutaline
hyperplasia
loricrin
keratin
gly0glu0thr0
capacity
tpn
bh0
homozygotes
neck
heritable
entacapone
rash
ugt
african-american
polish
highlight
0-hydroxy-0-methylglutaryl-coenzyme
question
ru-0
val0ile
fine
distinct
l0/l0
commercially-available
co-occurring
follow
conduct
changed
prescribing
reversed
hepatotoxic
process
quinpirole
success
nonfunctional
dexamethasone
ex
indians
at0
caucasians
unfavourable
gut-0
bat
rtq
canadian
familial
autonomic
immunization
mitochondria
ym-0
fda
quantitative
attempts
analysing
malaysian
rta
impulsivity
non-svr
neuropathy
polarizing
latter
best
dysfunction
shh
a0v
rather
cortical
mg/kg/0
han
respiration
wogonin
problems
atypia
finally
dystrophy
flecainide
periareolar
evoked
phsf
secretory
adp-ribose
mitotoxic
hepatoprotective
hmgcr
random
conclusions/significance
transmission
polyneuropathy
c/c
ii-driven
limb
isolated
generate
ml/min
muscular
bag-0
aspiration
intermittent
phosphodiesterase
woman
significance
asians
head
gctata
ecog
southeast
0-hne
ddei
differentiating
rtv
sucrose
consequently
altering
chick
ligand-independent
bud
prednisolone
abrogated
event-related
fk0
dio0
acenocoumarol
pantoprazole
crhr0
start
cluster
phenytoin
mpag
counterparts
address
ild
chose
measurable
ht0
azd0-hqpa
poly
cg
beta0-ar
consumes
imo
metabolized
amyloid
odn
rifampicin
needle
gabrg0
efficient
sufficient
triphosphatase
polymerase-0
remarkably
diagnosed
encephalopathy
domains
relations
a0-subunit
regimens
aids
produces
explained
cirrhotic
will
codon
females
glial
chop
incubated
cytogenetic
complete
mdr
front-line
deficits
bacterial
parkinson
hypothesize
agxt
diallyl
prediction
empty
sequenced
jbcrn
nigra
immunohistochemical
plasmid
interest
dihydropyrimidine
stratification
p.gly0glu
pparalpha
oseltamivir
immunoglobulin
prevents
c-myc
disulfide
saline
metabolize
ease
mab
initiation
corticosteroids
top0a
asmf
lymphocytes
aiau
typing
noted
dpd
biomarker
cytotoxic
scar
substantia
kit
mda-mb-0
avoiding
consented
vaccination
art
irradiation
fragment
interfering
pdac
deep
roles
least
observations
n-terminal
p-gp
bicalutamide
aws
soon
placement
n0t
unnoticed
modified
0tt
flutamide
measure
su0
surgery
initial
r0w
a0v/t
glioblastoma
independently
tdf
thalidomide
partially
y0c
extracted
mitogen-activated
degradation
stimulation-resistant
sulfamoyl
flg
spermatozoa
imiquimod
fak
n-acetyl
ccl
judged
immunostaining
p-aminobenzoic
venlafaxine
liposomes
app/ps0
double-strand
breaks
non-intoxications
hsfs
u
simplex
antioxidants
antibiotics
anemia
decisions
inhibitory
ab
nm
karyotype
0-aminosalicylate
proteinuria
worsen
feasible
psen0de0dbo
herpes
polyphenolic
close
zygotes
peg-ifn-alpha-0a
man
bryostatin-0
amplified
neuroprotective
c0bl/0
attenuated
nadph
intoxication
a-glucosidase
0svev
g0t
chromosomic
necessary
deficient
genome-wide
0e0
ptc
taste
hematological
pharmacogenomics
oxides
tissues
described
smad0
sulphamethazine
cognitive
ec0
misfolding
ear
efflux
costimulatory
check
biotransformation
inside
uracil
ior/os
ensues
offered
extra
ssg
appswe
w0
lobe
pregnane
dor-0
confirms
mid-digital
mediterranean
ventral
hair
eif0a
artificial
probe
upon
phenotyping
mpa
neo-adjuvant
hydrochloride
arg0gln
bcd
helpful
various
catalytic
fluorescence
orally-active
donor
neurotrophic
apoptosis-related
hmg
eto
requirement
nervous
like
substantially
i0
pulmonary
flt0
huntington
aldosterone
radiosensitize
releasing
nyholt
tryptophan
genetically-determined
0-fc
airways
discounted
low-fat
they
0,0-d
stmn0
declined
compound
sgce
presently
bound
drive
potentially
transmittance
pet
above
aspergillosis
cryptotanshinone
viremia
adriamycin
sonic
positron
up
tbhq
0his
nct0
http://clinicaltrials.gov/
aml0
mdm0
mineralocorticoid
cca
tanshinone
hpma
del0-0
corrected
propranolol
ig
stress-induced
regulating
sn-0g
0-hydroxydopamine
elective
lpv
cold
transduction
tool
vincristine
diffuse
accounts
ach
pyrimidine-0
d0a
light
ligand-binding
novo
demographic
levodopa
dopa
concentration/dose
coa
power
efv
mva
0-fluorocytosine
emission
oocytes
iia
prednisone
indicators
j0
tranylcypromine
resulting
synaptic
dose-dependently
mut
aurora
fluvastatin
doxifluridine
prophylactic
sv
last
asmko
hedgehog
jews
mild
epigallocatechin-gallate
conditioning
azacitidine
toll-like
modest
functions
biological
ttr
transfusion
pldim0
saha
withdrawn
optimise
methoxsalen
tomography
intolerant
nk
ameliorates
remains
concluded
de
conjugates
radiosensitizer
esr0
plateletworks
modestly
cobimetinib
nih0t0
corticotropin
t_t
flow
recommended
verifynow
consolidated
rituximab
eliminate
pdlim0
south
lacking
lta
co-segregate
b-cell
drink
hypomethylation-possibly
matrine
mol/l
popular
worthwhile
t-t-t-t-g
mimics
unlikely
assays
living-donor
mrp0
aggregometry
methiodide
recipient
pharmacoepigenetic
time-dependent
initiating
personalizing
tagging
phases
adp
evident
effector
cytosine
copolymer
certain
adequate
pak
observation
ldlt
inflammation
colon
preliminary
h0d
aza
diflunisal
mnsod
altogether
scd
lenalidomide
analogously
irinorecan
sch0
variables
cost-effective
unchanged
0-cyclohexyl-0-ethyl-0-methylpyrido
ibd
immunosuppressive
amodiaquine
children
linked
yohimbine
establishment
adenovirus-mediated
dnas
closed
mixture
hsv-tk
reach
every
abrogates
fibroblast
parkinsonian
definite
activate
myeloma
pc
neurotoxin
good
facets
conversely
0-mmol/l
subsequently
metformin
gcv
pharmacokinetic-pharmacodynamic
confirm
manifestations
augmentation
provocation
magnitude
crad
th
dopaminergic
fev
dr0
retina
adrs
extract
violence
macrocytosis
intraindividual
tpj
multiple-dose
stimulation
npm0
administered
:0.0
soyabean
i0v
tac
nos0a
mia0
cuff
gabaa
val0leu
pindolol
i0m
n0m
real-world
pna-aav0
over-represented
q0h
across
meta-analytic
ethnicities
segments
graft
care
single-centre
diagnostic
frequent
artery
considerable
geometric
black
0h0
contribution
wildtypes
naltrexone
mdr0a
o-galloylhyperin
accuracy
qd
successfully
point-mutated
quetiapine
publication
gastrointestinal
localization
absent
histocompatibility
extreme
nnrti
maxdrinks
srs
pivotal
conducted
valproate
july
lycopene
vector-mediated
xrcc0
sought
.0.0
heterogeneity
beyond
doi
s/s-allele
ldl-lowering
mg/dl
advance
g0e
oxypurinol
exploratory
abstinent
exhibit
ultrarapid
avoid
coli
preoperatively
probable
male-specific
potentiates
establish
describes
sensation
0-infinity
combinational
aldh0b0
metoprolol
vcam-0
crozotinib
anticoagulation
determinant
gc
explanation
il-0b
explain
sarcomatoid
efficiency
cckbr
possession
become
0gly
online
co-morbidity
allele-restricted
participants
epilepsy
hcc
0-fluorouracil-0-fudr
cocl0
ptgs0
journal
peg
t0i
0f
members
aminoglycoside
gain-of-function
carcinogenesis
gammah0ax
b-blocker/sympatholytic
fra
procarcinogens
breakdown
l/s
modulated
anticoagulant
myocytes
nshl
catabolism
beta0-adrenergic
viruses
strongest
gt
increasing
hydrolytic
rhodamine
cleaved
estrogens
ctl
inactivation
stat0
abl
prescribed
stz
metabolite
anti-inflammatory
line-derived
huntingtin
chromosome
srcl0
collies
m0l
cytochromes
delivery
dss-induced
0-ps
s/s
intolerance
gdnf
0-kda
inos
emerged
sn-0-glucuronide
neurotoxicity
stimulator
binds
knockouts
hearing
catechol-o-methyltransferase
hippocampal
bcr
haploinsufficiency
ifn
template
pasmc
star
silibinin
acquire
salmeterol
okadaic
env
mefloquine
epitope
pro-drug
civdr/pxra
down-regulated
trail
lysine
c/g
tgf-b0
placental
small-molecule
effectively
partly
pectenotoxin-0
modifier
drug-metabolizing
l/l
slices
postulated
catalyzes
acetyltransferases
retain
exons
cox0
acarbose
pertuzumab
microglobulinuria
glut0
medulloblastoma
mbc
adipoq
forced
calcineurin
rassf0a
han-chinese
lifetime
ern0
expiratory
scfas
mptp
remission
cost
mdx
complexed
thrombotic
detection
prolongs
dm0
st
angiography
globulin
lymphocyte
fpg
non-hematologic
replication
gly0gly
exon-skipping
functionalized
accumbal
aia
resequenced
logik0a
beneficial
tetrahydropyridine
adiponectin
phosphatidylcholine
bc
kyushu
pediatric
wnt
y0i
antithymocyte
rabbit
stavudine
multifactorial
gly0arg
prothrombotic
oncology
victims
person
v
copolymers
arg0arg
vinca
oligonucleotides
arterial
g0a
sulphonylurea
r-atg
,0,0,0
immunized
repeats
volume
butyrate
vinblastine
locomotor
variable
0-methyl-0-phenyl-0
cytotoxicity
alkaloids
monitoring
variance
projected
thymidine
epicutaneous
bilaterally
tale
nr0i0
ages
fe
atorvastatin
intermediate
acitretin
0alpha-hydroxylase
p.asp0fs
mg/kg/d
upregulated
0a/c
dpysl0
hippocampus
mug
anaplerotic
acquisition
sbp
atp
tas0r0
erk0
food
respiratory
neuropeptide
endothelium
peroxide
need
intramuscular
significiantly
donors
nme0
acetaldehyde
ntr
p-0
injected
side
seven
sodium
questionnaire
hydrolase
mm
vasodilation
l0-l0
bo-0
sibutramine
escherichia
nfatc0
habits
degeneration
human-0
verapamil
few
icam-0
aggregation
0,0-butadiene
hrt0b
bipolar
course
tri-phosphate
dmxaa
obese
fluoropyrimidines
h0-antihistamine
alpha0c-ar
encode
bi-tk
sfrs0
executive
isoflavone
apolipoprotein
cea
i.p.-primed
robust
marcks
dtnbp0
neuroendocrine
orlistat
flu
xiii
parasites
hage
akr-0
life
xanthone
consistently
assessing
probucol
mc0r
amprenavir
reinfecting
autopsy
localized
quantify
brain-derived
shunting
captopril
acth
im0
toxicology
po
ppvn
samples
oxycodone
brachytherapy
wild-types
limitations
routes
hydrogen
withstand
c0-c0
wm
pept0
bisacurone
cefadroxil
polyphenolics
aldh-0
cni
anteroventral
ng/ml
intragastric
0y/y0/0y
co-expression
sequence
enantioselective
gata0
retinoid
cortex
competitive
mephenytoin
ipsilaterally
oridonin
forensic
intron
plasticity
thrombocytopenia
glucuronide
ptca
raltegravir
nitroreductase
ph
hypersomnia
vector
debrisoquine
lopinavir
tph0
intake
hu
follicular
gt0a0
rgh
pna
adenovirus
elderly
liability
yang
fluid
wca
gnrh
pahs
coagulation
ccr0
regarded
hepcidin
yin
naringenin
vpa
0i
periventricular
sds
semiquantitative
d0n
subtype
arg0
peg-ifn
ins
thought
ltp
consortium
fcgr0a
antimode
suitable
del
chosen
vrx-0
bcr/abl
cpic
kcnq0
bucindolol
ranbp0
s-methyl
context
gly
microm
0-mp
exact
ineffective
zidovudine
gnb0
potentiation
pretetanic
kif0a
dystrophin
needs
implementation
guidelines
bcr-abl
intracellular
proglucagon
d0g
g-rg0
s.
achieving
pramipexole
perception
knockdown
individualised
exerts
reasons
nephrotoxicity
tolerability
cysteine
derivatives
n-desethylaminodiaquine
milbemycin
kv0
methylphenidate
healthy-volunteer
stenosis
scanning
nalbuphine
rrna
pdgfr
times
variabilities
lithospermate
gtpase
olanzapine
true
adora0a
nateglinide
proteoliposomes
caspase0
crbp
il0rn
pon0
propionate
descending
ortholog
cycle
hydrochlorothiazide
ameliorate
dex
butyric
planar
igf-0
ryr0
n0/0f/d0
hepg0
magnesium
eradication
residues
routinely
sumatriptan
budesonide
responsiveness
highlights
thromboembolic
polg
quinazoline
psychiatric
atenolol
nodat
expectancy
clozapine
ecstasy
kcna0
pei
optimal
desipramine
circadian
why
separation
validation
tpo
0s
low-activity
loop
omeprazole
individualization
retinol
nonlinear
quality-adjusted
sharply
mfg-e0
h.
diazoxon
valerenic
gatekeeper
aq
bk0r
hetero-monocyclic
removed
anxiolytic
infant
arenethynyl
fcyriiia
narrow
insights
maprotiline
omacetaxine
cml
s-mephenytoin
average
cysteines
0-aminopyridine
spinosad
cxcr0
hba0c
flux-based
except
t-lymphocytes
replacement
calcium-sensing
xbp0
incorporated
difficulties
cells/animal
pombe
bilayers
pylori
colitis
arcuate
considerations
cost-effectiveness
sudden
fluticasone
0-oxime
fcer0
proguanil
camkii
deacetylase
reactive
metabolisers
ryanodine
differentiates
cpp
methadone
gr
